GlycoMimetics' Uproleselan: Navigating Clinical And Financial Complexities In AML Seeking Alpha, 27 Nov 2023 Summary GlycoMimetics' uproleselan shows promise in AML, but Phase 3 trial changes introduce data interpretation and regulatory…